Serum levels of PIVKA-II and AFP and the serum γ-GT/ALT ratio were not correlated with serum levels of HBV DNA in patients with HCC who were positive for HBV DNA (P = 0.503, P = 0.248, and P = 0.336, respectively; Fig. 3G–I). The gene discussed is GPT; the disease is hepatocellular carcinoma.